CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...
Phase 2
Kansas City, Kansas, United States and 6 other locations
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...
Phase 2
Kansas City, Kansas, United States and 6 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Kansas City, Missouri, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Fairway, Kansas, United States and 66 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Kansas City, Missouri, United States and 33 other locations
against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine, MV-014-212, is a li...
Phase 1
Lenexa, Kentucky, United States of America and 1 other location
The main goal of this study is to evaluate the safety, reactogenicity, and immunogenicity of study vaccines.
Phase 1
Lenexa, Kansas, United States and 7 other locations
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-8922...
Phase 1
Lenexa, Kansas, United States and 1 other location
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Kansas City, Kansas, United States and 446 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...
Phase 3
Kansas City, Kansas, United States and 246 other locations
Clinical trials
Research sites
Resources
Legal